Long-Term Oncological Outcomes in Patients Diagnosed With Nonmetastatic Plasmacytoid Variant of Bladder Cancer: A 20-Year University of Texas MD Anderson Cancer Center Experience-Reference-Cited by-同舟云学术

Long-Term Oncological Outcomes in Patients Diagnosed With Nonmetastatic Plasmacytoid Variant of Bladder Cancer: A 20-Year University of Texas MD Anderson Cancer Center Experience

Published:2024-02 Issue:2 Volume:211 Page:241-255
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Sood Akshay¹²^ORCID,Rudzinski Jan K.¹,Labbate Craig V.¹,Hensley Patrick J.¹,Bree Kelly K.¹,Guo Charles C.³,Alhalabi Omar⁴,Campbell Matthew T.⁴,Siefker-Radtke Arlene O.⁴,Navai Neema¹,Dinney Colin P. N.¹,Gao Jianjun⁴,Kamat Ashish M.¹

Affiliation:

1. Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas

2. Department of Urology, The James Cancer Hospital and Solove Research Institute, The Ohio State University Wexner Medical Center, Columbus, Ohio

3. Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas

4. Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Link

http://www.auajournals.org/doi/pdf/10.1097/JU.0000000000003778

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating Treatment Patterns and the Role of Neoadjuvant Chemotherapy in Plasmacytoid Urothelial Carcinoma: Insights from a Combined National and Institutional Series;Cancers;2024-09-01

2. The Prognostic and Therapeutic Potential of Fragile X Mental Retardation 1 (FMR1) Gene Expression in Prostate Adenocarcinoma: Insights into Survival Outcomes and Oncogenic Pathway Modulation;International Journal of Molecular Sciences;2024-07-02

3. Editorial Comment;Journal of Urology;2024-02

4. Editorial Comment;Journal of Urology;2024-02

5. Editorial Comment;Journal of Urology;2024-02